Home Evaluation of the Becton-Dickinson rapid serum tube: does it provide a suitable alternative to lithium heparin plasma tubes?
Article
Licensed
Unlicensed Requires Authentication

Evaluation of the Becton-Dickinson rapid serum tube: does it provide a suitable alternative to lithium heparin plasma tubes?

  • Goce Dimeski , Paul P. Masci , Manuela Trabi , Martin F. Lavin and John de Jersey
Published/Copyright: March 11, 2010

Abstract

Background: Obtaining a suitable specimen for analysis in a timely manner is pivotal in clinical chemistry service provision. Serum is recognized as the preferred specimen for most assays, but because of time constraints for completion of clotting and an increasing number of patients on anti-coagulant therapy, latent clotting or no clotting is an outcome which can lead to errors and delay in delivery of critical results. Although lithium heparin plasma has unique problems, it has become an alternative in hospital-based laboratories.

Methods: The Becton-Dickinson (BD) rapid serum tube (RST) was evaluated in a hospital environment using a total of 53 participants, both healthy and anticoagulated, for 31 analytes against BD PST II and BD SST II tubes measured with Beckman DxC800 and DxI800 analyzers.

Results: Most results from the RST tube were comparable with those from the SST II tube. Potassium results were closer to the PST II plasma concentrations. Incomplete and latent clotting was encountered in the RST specimens from participants (cardiac and dialysis) who had received a total of >7000 units of heparin [activated partial thromboplastin time (APTT) >150 s], warfarin/heparin combination, and specimens from cardiac surgery patients who had received a total of >25,000 units of heparin (APTT >200 s) at the time of collection of specimens.

Conclusions: The RST tube provides a suitable alternative to lithium heparin plasma tubes for most patients in a hospital environment. However, latent clotting continued to occur in specimens collected from participants who had received high concentrations of anticoagulants.

Clin Chem Lab Med 2010;48:651–7.


Corresponding author: Goce Dimeski, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia Phone: +61-7-3240-5082, Fax: +61-7-3240-7070, ;

Received: 2009-8-19
Accepted: 2010-1-12
Published Online: 2010-03-11
Published in Print: 2010-05-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Laboratory medicine and natural disasters: are we ready for the challenge?
  3. Reference values: still a critical issue in laboratory medicine
  4. Review
  5. Contemporary platelet function testing
  6. Minireviews
  7. Disasters: where they find us
  8. Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall
  9. Opinion Paper
  10. Glycated hemoglobin (HbA1c): old dogmas, a new perspective?
  11. Guidelines and Recommendations
  12. IFCC reference procedures for measurement of the catalytic concentrations of enzymes: corrigendum, notes and useful advice
  13. Recommendations for the implementation of international standardization of glycated hemoglobin in Italy
  14. Genetics and Molecular Diagnostics
  15. UGT2B17 and SULT1A1 gene copy number variation (CNV) detection by LabChip microfluidic technology
  16. Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers
  17. Automated genomic DNA extraction from saliva using the QIAxtractor
  18. General Clinical Chemistry and Laboratory Medicine
  19. A new statistical method for evaluating long-term analytical performance of laboratories applied to an external quality assessment scheme for flow cytometry
  20. Evaluation of the Becton-Dickinson rapid serum tube: does it provide a suitable alternative to lithium heparin plasma tubes?
  21. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders
  22. Evaluation of the new body fluid mode on the Sysmex XE-5000 for counting leukocytes and erythrocytes in cerebrospinal fluid and other body fluids
  23. Extracellular haemoglobin, oxidative stress and quality of red blood cells relative to perioperative blood salvage
  24. Positive predictive value of serological diagnostic measures in celiac disease
  25. Retinol potentiates the inhibitory effect of ascorbic acid on uric acid assay
  26. Reference Values and Biological Variations
  27. Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform
  28. Factors influencing serum total tryptase concentrations in a general adult population
  29. Leptin and adiponectin levels in pubertal children: relationship with anthropometric variables and body composition
  30. Cardiovascular risk factors and γ-glutamyltransferase fractions in healthy individuals
  31. Cancer Diagnostics
  32. Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer
  33. Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation: a 16-year experience
  34. Letters to the Editor
  35. Methodological weakness in using correlation coefficients for assessing the interchangeability of analyte data between samples collected under different sampling conditions – the example of matrix metalloproteinase 9 determined in serum and plasma samples
  36. Intralipid causes falsely increased glucose concentrations with the Hemocue glucose analyzer
  37. Serum cholesterol: required and actual bias values
  38. Abstracts
  39. ISMD2010 Eighth International Symposium on Molecular Diagnostics
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.141/html
Scroll to top button